Stryker Tries To Limit Bone Device Marketing Charges
Stryker Biotech LLC and four current and former executives are seeking to trim criminal allegations that they falsely marketed devices used in invasive bone surgeries, arguing that federal prosecutors brought the...To view the full article, register now.
Already a subscriber? Click here to view full article